Hundahl SA, Fleming ID, Fremgen AM, Menck HR. (1998) A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]. Cancer. 83:2638–2648.

Article  CAS  PubMed  Google Scholar 

Tang KT, Lee CH. (2010) BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications. J Chin Med Assoc. 73:113–128.

Article  CAS  PubMed  Google Scholar 

Mazzaferri EL, Jhiang SM. (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 97:418–428.

Article  CAS  PubMed  Google Scholar 

Baxa CA, Sha RS, Buelt MK, Smith AJ, Matarese V, Chinander LL, Boundy KL, Bernlohr DA. (1989) Human adipocyte lipid-binding protein: purification of the protein and cloning of its complementary DNA. Biochemistry. 28:8683–8690.

Article  CAS  PubMed  Google Scholar 

Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, Parker RA, Suttles J, Fazio S, Hotamisligil GS, Linton MF. (2001) Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med. 7:699–705.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hotamisligil GS, Bernlohr DA. (2015) Metabolic functions of FABPs--mechanisms and therapeutic implications. Nat Rev Endocrinol. 11:592–605.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hansson GK, Hermansson A. (2011) The immune system in atherosclerosis. Nat Immunol. 12:204–212.

Article  CAS  PubMed  Google Scholar 

Furuhashi M, Saitoh S, Shimamoto K, Miura T. (2014) Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases. Clinical Medicine Insights Cardiology. 8:23–33.

PubMed  Google Scholar 

Scifres CM, Chen B, Nelson DM, Sadovsky Y. (2011) Fatty acid binding protein 4 regulates intracellular lipid accumulation in human trophoblasts. J Clin Endocrinol Metab. 96:E1083–1091.

Article  PubMed  PubMed Central  Google Scholar 

Cecchini MJ, Amiri M, Dick FA. (2012) Analysis of cell cycle position in mammalian cells. J Vis Exp 21:3491.

Google Scholar 

Prentice KJ, Saksi J, Hotamisligil GS. (2019) Adipokine FABP4 integrates energy stores and counterregulatory metabolic responses. Journal of Lipid Research. 60:734–740.

Tang Z, Shen Q, Xie H, Zhou X, Li J, Feng J, Liu H, Wang W, Zhang S, Ni S. (2016) Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC). Oncotarget. 7:46253–46262.

Article  PubMed  PubMed Central  Google Scholar 

Mukherjee A, Chiang CY, Daifotis HA, Nieman KM, Fahrmann JF, Lastra RR, Romero IL, Fiehn O, Lengyel E. (2020) Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance. Cancer Research. 80:1748–1761.

Zhang Y, Zhang W, Xia M, Xie Z, An F, Zhan Q, Tian W, Zhu T. (2021) High expression of FABP4 in colorectal cancer and its clinical significance. J Zhejiang Univ Sci B. 22:136–145.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hao J, Yan F, Zhang Y, Triplett A, Zhang Y, Schultz DA, Sun Y, Zeng J, Silverstein KAT, Zheng Q, Bernlohr DA, Cleary MP, Egilmez NK, Sauter E, Liu S, Suttles J, Li B. (2018) Expression of Adipocyte/Macrophage Fatty Acid-Binding Protein in Tumor-Associated Macrophages Promotes Breast Cancer Progression. Cancer Res. 78:2343–2355.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhong CQ, Zhang XP, Ma N, Zhang EB, Li JJ, Jiang YB, Gao YZ, Yuan YM, Lan SQ, Xie D, Cheng SQ. (2018) FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma. Cancer Med. 7:2629–2640.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Z, Jeong JH, Ren C, Yang L, Ding L, Li F, Jiang D, Zhu Y, Lu J. (2021) Fatty Acid-Binding Protein 4 (FABP4) Suppresses Proliferation and Migration of Endometrial Cancer Cells via PI3K/Akt Pathway. Onco Targets Ther. 14:3929–3942.

Article  PubMed  PubMed Central  Google Scholar 

Dom G, Frank S, Floor S, Kehagias P, Libert F, Hoang C, Andry G, Spinette A, Craciun L, de Saint Aubin N, Tresallet C, Tissier F, Savagner F, Majjaj S, Gutierrez-Roelens I, Marbaix E, Dumont JE, Maenhaut C. (2018) Thyroid follicular adenomas and carcinomas: molecular profiling provides evidence for a continuous evolution. Oncotarget. 9:10343–10359.

Article  PubMed  Google Scholar 

Yang J, Liu X, Shao Y, Zhou H, Pang L, Zhu W. (2022) Diagnostic, Prognostic, and Immunological Roles of FABP4 in Pancancer: A Bioinformatics Analysis. Comput Math Methods Med. 2022:3764914.

Article  PubMed  PubMed Central  Google Scholar 

Li J, Mi L, Ran B, Sui C, Zhou L, Li F, Dionigi G, Sun H, Liang N. (2023) Identification of potential diagnostic and prognostic biomarkers for papillary thyroid microcarcinoma (PTMC) based on TMT-labeled LC-MS/MS and machine learning. J Endocrinol Invest. 46:1131–1143.

Article  CAS  PubMed  Google Scholar 

Edge SB, Compton CC. (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17:1471–1474.

Tuttle RM, Haugen B, Perrier ND. (2017) Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why? Thyroid. 27:751–756.

Article  PubMed  PubMed Central  Google Scholar 

Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 102:15545–15550.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng CW, Fang WF, Tang KT, Lin JD. (2022) The pathogenic role of IFN-alpha in thyroiditis mouse models. Life Sci. 288:120172.

Article  CAS  PubMed  Google Scholar 

Xu A, Wang Y, Xu JY, Stejskal D, Tam S, Zhang J, Wat NM, Wong WK, Lam KS. (2006) Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem. 52:405–413.

Article  CAS  PubMed  Google Scholar 

Xu A, Tso AW, Cheung BM, Wang Y, Wat NM, Fong CH, Yeung DC, Janus ED, Sham PC, Lam KS. (2007) Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation. 115:1537–1543.

Article  CAS  PubMed  Google Scholar 

Tso AW, Xu A, Sham PC, Wat NM, Wang Y, Fong CH, Cheung BM, Janus ED, Lam KS. (2007) Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care. 30:2667–2672.

Article  CAS  PubMed  Google Scholar 

Ota H, Furuhashi M, Ishimura S, Koyama M, Okazaki Y, Mita T, Fuseya T, Yamashita T, Tanaka M, Yoshida H, Shimamoto K, Miura T. (2012) Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation. Am J Hypertens. 25:1124–1130.

Article  CAS  PubMed  Google Scholar 

Yeung DC, Xu A, Cheung CW, Wat NM, Yau MH, Fong CH, Chau MT, Lam KS. (2007) Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 27:1796–1802.

Article  CAS  PubMed  Google Scholar 

Zeng J, Sauter ER, Li B. (2020) FABP4: A New Player in Obesity-Associated Breast Cancer. Trends Mol Med. 26:437–440.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gharpure KM, Pradeep S, Sans M, Rupaimoole R, Ivan C, Wu SY, Bayraktar E, Nagaraja AS, Mangala LS, Zhang X, Haemmerle M, Hu W, Rodriguez-Aguayo C, McGuire M, Mak CSL, Chen X, Tran MA, Villar-Prados A, Pena GA, Kondetimmanahalli R, Nini R, Koppula P, Ram P, Liu J, Lopez-Berestein G, Baggerly K, L SE, Sood AK. (2018) FABP4 as a key determinant of metastatic potential of ovarian cancer. Nat Commun. 9:2923.

Article  PubMed  PubMed Central